BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 17631431)

  • 21. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC; Luketich JD; Friedman D; Charron M; Strollo D; Meehan M; Urso GK; Dachille MA; Townsend DW
    Clin Nucl Med; 2000 Nov; 25(11):882-7. PubMed ID: 11079584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team.
    Berrisford RG; Wong WL; Day D; Toy E; Napier M; Mitchell K; Wajed S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1112-6. PubMed ID: 18328726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
    Schreurs LM; Janssens AC; Groen H; Fockens P; van Dullemen HM; van Berge Henegouwen MI; Sloof GW; Pruim J; van Lanschot JJ; Steyerberg EW; Plukker JT
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1021-1028. PubMed ID: 21547703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of FDG-PET in the preoperative staging of esophageal cancer.
    Gananadha S; Hazebroek EJ; Leibman S; Berry H; Osgood L; Shon IH; Pavlakis N; Marx G; Smith GS
    Dis Esophagus; 2008; 21(5):389-94. PubMed ID: 19125791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
    Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Sundaresan SR; Patterson GA; Cooper JD
    AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].
    Pifarré-Montaner P; Fernández-León A; de Juan R; del Ama-Salvador ME; Galán M; Gámez-Cenzano C; Sans M
    Rev Esp Med Nucl; 2009; 28(3):101-5. PubMed ID: 19558949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
    Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
    Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy.
    Lerut T; Flamen P; Ectors N; Van Cutsem E; Peeters M; Hiele M; De Wever W; Coosemans W; Decker G; De Leyn P; Deneffe G; Van Raemdonck D; Mortelmans L
    Ann Surg; 2000 Dec; 232(6):743-52. PubMed ID: 11088069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.
    Fencl P; Belohlavek O; Harustiak T; Zemanova M
    Abdom Radiol (NY); 2016 Nov; 41(11):2089-2094. PubMed ID: 27405645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
    Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of PET scan in the preoperative management of oesophageal cancer.
    Liberale G; Van Laethem JL; Gay F; Goldman S; Nagy N; Coppens E; Gelin M; El Nakadi I
    Eur J Surg Oncol; 2004 Nov; 30(9):942-7. PubMed ID: 15498638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?
    Torrance AD; Almond LM; Fry J; Wadley MS; Lyburn ID
    Surgeon; 2015 Feb; 13(1):19-33. PubMed ID: 24206935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited additional value of positron emission tomography in staging oesophageal cancer.
    van Westreenen HL; Westerterp M; Sloof GW; Groen H; Bossuyt PM; Jager PL; Comans EF; van Dullemen HM; Fockens P; Stoker J; van der Jagt EJ; van Lanschot JJ; Plukker JT
    Br J Surg; 2007 Dec; 94(12):1515-20. PubMed ID: 17902092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
    J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations.
    van Westreenen HL; Heeren PA; van Dullemen HM; van der Jagt EJ; Jager PL; Groen H; Plukker JT
    J Gastrointest Surg; 2005 Jan; 9(1):54-61. PubMed ID: 15623445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach?
    Kneist W; Schreckenberger M; Bartenstein P; Grünwald F; Oberholzer K; Junginger T
    World J Surg; 2003 Oct; 27(10):1105-12. PubMed ID: 12917769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma.
    Purandare NC; Pramesh CS; Karimundackal G; Jiwnani S; Agrawal A; Shah S; Kulkarni M; Laskar SG; Rangarajan V
    Nucl Med Commun; 2014 Aug; 35(8):864-9. PubMed ID: 24751701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of [18]-FDG PET/CT in the initial staging of head and neck cancers].
    Fakhry N; Barberet M; Lussato D; Mundler O; Giovanni A; Zanaret M
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):3-9. PubMed ID: 17633658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.
    Rankin SC; Taylor H; Cook GJ; Mason R
    Clin Radiol; 1998 Sep; 53(9):659-65. PubMed ID: 9766719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.